Shuttle Pharmaceuticals Holdings, Inc.

NASDAQ: SHPH · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Gaithersburg, MD · MontgomeryCIK 0001757499Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 24DQ —GM —SS 17

v0.1 · 35/100 weight · pillars only

↑ Altman-Z, balance-sheet leverage · ↓ Piotroski F, workforce scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$11.7M

Employees

as of 2026-08-25

Market cap

$2.1M

as of 2026-08-25

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$11.7M-$11.7M2025

Operating income-$11.9M-$11.9M2025

Total assets$10.5M$10.5M2025

Liabilities$8.2M$8.2M2025

Equity$2.3M$2.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Shuttle Pharmaceuticals Holdings, Inc.’s financial profile?

Shuttle Pharmaceuticals Holdings, Inc. earned -$11.7M in FY2025 net income.

Peers · Healthcare

Artelo Biosciences, Inc.——Restart Life Sciences Corp.——1933 Industries Inc.——Algernon Pharmaceuticals Inc.——Kelyniam Global, Inc.——Stemsation International, Inc.——

Neighbors

Montgomery →

Lockheed Martin Corporation$75.0B81B+Marriott International, Inc.$26.2B82B+United Therapeutics Corporation$3.2B92A Host Hotels & Resorts, Inc.$6.1B69B AGNC Investment Corp.——Federal Realty Investment Trust$1.3B75B+

Key facts

CEOChristopher Robert Cooper

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersGaithersburg, MD

ExchangeNASDAQ: SHPH

Employees2

IPO date2022-08-31

Latest filings

8-K2026-08-28 DEF 14A2026-08-13 8-K2026-07-01 8-K2026-06-11 8-K2026-05-27 10-Q2026-05-15 8-K2026-05-07 8-K2026-05-01

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.